You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation
|
|---|---|
| Published in |
European Heart Journal - Cardiovascular Pharmacotherapy, May 2024
|
| DOI | 10.1093/ehjcvp/pvae032 |
| Pubmed ID | |
| Authors |
K Enge, A Tveit, S Enger, S Onarheim, A H Pripp, P S Rønningen, M G Solberg, R Byrkjeland, K Andresen, A Halsen, H A Aulie, T Steinsvik, C Hall, S R Ulimoen |
X Demographics
The data shown below were collected from the profiles of 95 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 6 | 6% |
| United States | 5 | 5% |
| Spain | 5 | 5% |
| Italy | 4 | 4% |
| France | 4 | 4% |
| Greece | 3 | 3% |
| Australia | 3 | 3% |
| Turkey | 3 | 3% |
| Colombia | 3 | 3% |
| Other | 25 | 26% |
| Unknown | 34 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 66 | 69% |
| Scientists | 15 | 16% |
| Practitioners (doctors, other healthcare professionals) | 11 | 12% |
| Science communicators (journalists, bloggers, editors) | 3 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 2 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 1 | 50% |
| Unknown | 1 | 50% |
| Readers by discipline | Count | As % |
|---|---|---|
| Economics, Econometrics and Finance | 1 | 50% |
| Unknown | 1 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 56. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2024.
All research outputs
#779,055
of 25,978,998 outputs
Outputs from European Heart Journal - Cardiovascular Pharmacotherapy
#54
of 573 outputs
Outputs of similar age
#7,737
of 225,770 outputs
Outputs of similar age from European Heart Journal - Cardiovascular Pharmacotherapy
#2
of 15 outputs
Altmetric has tracked 25,978,998 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 573 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,770 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.